LCM
YARW

Lynx1 Capital Management’s Yarrow Bioscience YARW Stock Holding History

Lynx1 Capital Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Hold
32,574
– – 0.12% 14
2026
Q1 		$973K Buy
+32,574
New +$950K 0.15% 17
2024
Q4 		– Sell
-324
Closed -$30.4K – 23
2024
Q3 		$30.4K Hold
324
– – 0.01% 18
2024
Q2 		$31.9K Buy
+324
New +$40.4K 0.01% 17

Other funds holding YARW

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Lynx1 Capital Management's YARW Position: Q2 2026 in Review

Lynx1 Capital Management held its Yarrow Bioscience (YARW) position steady in Q2 2026 at 32,574 shares worth $1.06M. The position accounts for 0.12% of the portfolio, ranked #14.

Lynx1 Capital Management first reported a position in YARW in Q2 2024 and has held it in 4 quarters since. 40 funds tracked by Wall St. Rank hold YARW as of Q2 2026.

  • Lynx1 Capital Management held 32,574 shares of Yarrow Bioscience worth $1.06M as of Q2 2026.
  • Lynx1 Capital Management left its Yarrow Bioscience share count unchanged in Q2 2026.
  • Yarrow Bioscience made up 0.12% of Lynx1 Capital Management's portfolio in Q2 2026, its #14 holding.
  • Lynx1 Capital Management first reported a position in Yarrow Bioscience in Q2 2024 and has held it in 4 quarters since.
  • 40 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q2 2026.

Based on Lynx1 Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.